Skip To Main Content
Selcen Ari Yuka on Muck Rack

Selcen Ari Yuka

As seen in: Wiley Online Library
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Selcen Ari

Contact Selcen Ari, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Nitidine and Paclitaxel‐Coloaded Lipid-Chitosan Hybrid Nanoparticles Overcoming ABCB1‐Mediated Multidrug Resistance in Ovarian Cancer

|
By Elif Durasi, Hilal Çalik, Selcen Ari Yuka, Rabia Yilmaz Ozturk
| Wiley Online Library Verified
Conflict of Interests The authors declare no conflict of interest. References 1, , , , , , Oncol. Rep. 2022, 47, 82. 2, , , , , , , CA: Cancer. J. Clin. 2021, 71, 209. 3, , , , , , , , , J Nanobiotechnol. 2021, 19, 444. 4, , , , , , , , Oncotarget 2018, 9, 14741. 5, , , Cancers 2022, 14, 6246. 6, , , Front. Pharmacol. 2024, 14, 1340401. 7, , , , Int. J. Mol. Sci. 2020, 21, 7768. 8, , , , , , , , Br. J. Cancer 2024, 130, 703. 9, , , Drug Resistance Updates 2023, 71, 101011.
Open in Who Shared Issue with article?
See all 1 articles